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The role of diabetic nephropathy in the outcome of acute renal injury (AKI) is not well defined. Herein we evaluate the outcome
of lipopolysaccharide- (LPS-) induced AKI in streptozotocin-induced diabetes, as well as the potential role of Hypoxia Inducible
Factor (HIF-1𝗼) in this condition. Although 6h after LPS injection all mice developed a decrease in renal function, proteinuric
diabetic mice showed a better recovery of this parameter throughout the study (72h). Both HIF-1𝗼 and vascular endothelium
growth factor (VEGF) were found to be upregulated in diabetic mice. After LPS injection, all animals showed an upregulation
of these factors, although it was higher in the diabetic group. Glycated albumin (GA) was found to upregulate HIF-1𝗼 in HK-
2 cells, which resulted in increased production of VEGF. Interestingly, LPS cooperated with GA to induce HIF-1𝗼 upregulation.
In conclusion, diabetic mice display a better recovery of AKI after experimental endotoxemia. Moreover, these animals showed
a ni n c r e a s e de x p r e s s i o no fb o t hH I F - 1 𝗼 and VEGF that was reproduced by incubating renal cells with GA. Since VEGF is
considered a survival factor for tubular cells, our findings suggest that diabetes displays HIF-1𝗼 upregulation that might function
as a “precondition state” offering protection from endotoxic AKI.
1. Introduction
Theroleofdiabetesintheoutcomeofacuterenalinjury(AKI)
isnotwellunderstoodandmaydependuponthecauseofthe
injury as well as on the stage of diabetic renal involvement.
Among the various causes of AKI, endotoxemia, a major
component of sepsis, remains an elusive and challenging
condition which is still lacking treatment. Although it is
known that rodentswithexperimentaldiabetes are protected
from certain nephrotoxic agents [1–3], diabetes has been
recognizedasanindependentriskfactorforthedevelopment
of AKI in a variety of clinical settings, including sepsis [4–8].
Hypoxia-inducible factor (HIF-1𝗼)a l l o w st h ea d a p t i v e
response to hypoxia by stimulating the expression of target
genes such as erythropoietin, enzymes involved in glucose
metabolism, and the vascular endothelial growth factor A
(VEGF-A) [9]. The later has been recognized as a survival
factor for proximal tubular cells [10].
HIF-1𝗼isaheterodimertranscriptionfactorconsistingof
aconstitutivelyexpressed𝗽subunitandtwo𝗼subunits,HIF-
1𝗼 or HIF-2𝗼. In normoxia, HIF-1𝗼 is continuously synthe-
sized but rapidly ubiquitinated and subsequently degraded
by the cellular proteasome [11]. Under hypoxia, the HIF-
1𝗼 ubiquitination is suppressed. HIF-1𝗼 protein is thereby
stabilized, it translocates to the nucleus, and together with
the 𝗽 subunit and transcriptional coactivators, it binds to
hypoxia-responsive elements (HRE) in target genes [12, 13].
Besides hypoxia, several physiological regulators such as2 Journal of Diabetes Research
growth factors, hormones, stress factors, and inflammatory
mediators, increase HIF-1𝗼 expression in normoxia [14].
Moreover, HIF-1𝗼 i sa l s oi n d u c e du p o nd i a b e t i cc o n d i t i o n
withapotentialroleinwoundhealing[15].ActivationofHIF-
1𝗼bycobaltchloridehastherapeuticbenefitinseveralkidney
disease models including ischemia reperfusion, cisplatin
nephropathy, remnant kidney, progressive anti-Thy1 nephri-
tis,anddiabeticnephropathy,reviewedbyNangakuetal.[16].
LessisknownaboutthepotentialroleofHIF-1𝗼inAKIdueto
endotoxemia. Moreover, most of the available data are based
upon experimental models of early diabetic stage, which
might not recapitulate a long-term disease such as diabetic
nephropathy, a condition characterized by an increase in
urinary albumin excretion (UAE) [17]. There is also tubular
injury, which is due to several factors, particularly high glu-
coselevels,albuminuria,andthepresenceofadvancedglyca-
tion end-product (AGE-) modified proteins [17, 18].
The aim of the present study was to evaluate the outcome
of AKI in animals with experimental diabetes after the
development of an increase in the UAE. Moreover, we also
investigate the potential role of HIF-1𝗼 in this outcome.
2. Material and Methods
In all of the experiments, adult CD-1 mice (4–8 months old,
𝑛=1 0 –15 per group, total 104) were used. The experimental
procedures were previously approved by the Committee
for Animal Ethics of Alcal´ a University, in accordance with
the Spanish and European Guidelines. AKI was induced
by intraperitoneal injection of lipopolysaccharide (LPS)
(10mg/Kg) (from E. Coli, Sigma) in mice at different periods
(6–72h). In some animals, diabetes was induced by three
consecutive daily intraperitoneal injections of streptozotocin
(STZ)(Sigma,St.Louis,MO,USA),65mg/kgbodyweightin
citratebuffer,pH4.5(vehicle)6weeksbeforeLPSin jury .This
is a previously reported model of early diabetic nephropathy
characterizedbyincreasedUAEduringthefirstmonthofdia-
betes [19]. After the last STZ injection, induction of diabetes
was confirmed by measurement of blood glucose levels.
Animals with blood glucose >300mg/dL were included in
the study.
Animals were individually housed in metabolic cages
with free access to food and tap water, and 24-hour urine
was collected for protein measurement. Blood was taken by
cardiac puncture under ether anaesthesia, and plasma glu-
cose was determined [19]. Urinary albumin excretion (UAE),
endogenous creatinine clearance (CCr), urinary volume
(UV), and fractional excretion of sodium (NaFE) (Na𝑢×
Cr𝑠)]/[Na𝑠× Cr𝑢] × 100) were analyzed. One kidney of each
animal was removed, weighed, frozen in liquid nitrogen,
and stored at −80
∘C for subsequent total protein and RNA
extraction. The remaining kidney was fixed in 10% (v/v)
formaldehydeinPBS,embeddedinparaffin,andsectionedat
5𝜇m for morphological and immunohistochemistry studies.
2.1. Renal Expression and Immunolocalization of HIF-1𝗼 and
VEGF-A. Western blotting in tissue was performed as previ-
ouslydescribed[20].Briefly,asmallpieceofkidneywaslysed
in RIPA buffer and centrifuged for preclearance, and total
protein was loaded into 8% acrylamide SDS gels and trans-
ferred to PVDF membrane. The membrane was incubated
withanti-mouseanti-HIF-1𝗼(R&DSystems,Inc,MN,USA),
1/500 and appropriate HRP-conjugated secondary anti-
body.
Sections were deparaffinised, rehydrated, and placed in
10mMsodiumcitratebuffer,pH6.0,andheatedinapressure
cooker for 2min. The sections were allowed to cool for
20min. After rinsing with distilled water, the sections were
w a s h e dt w i c ei nT B Sb u ff e r ,p H7 . 6 ,f o r5m i n .Th ee n d o g e -
nousperoxidaseactivitywasinhibitedbyincubationwith3%
H2O2 f o r2 0m i n .S e c t i o n sw e r ew a s h e dw i t hH 2O and TBS
andincubatedwith3%normaldonkeyserumplus0.05%Tri-
ton X-100 in TBS, pH 7.6, at room temperature for 45min, to
prevent nonspecific binding of the first antibody. Afterwards,
t h es e c t i o n sw e r ei n c u b a t e do v e r n i g h ta t4
∘C, with the fol-
lowing rabbit polyclonal antibodies: HIF-1𝗼 (Abcam, Cam-
bridge,UK)diluted1:300andVEGF-A(SantaCruzBiotech-
nology, Lamecula, CA, USA) diluted 1:500 in the blocking
solution diluted 1:9. Then, the sections were washed in
TBS, and detection was made by the conventional labelled-
streptavidin-biotin method (LSAB-kit, Dako). The perox-
idase activity was detected using the DAB kit (Master
Diagnostica, Granada, Spain). Tissue sections were coun-
terstained with hematoxylin, dehydrated, cleared in xylene,
andmountedinEntellan(Merck,Darmstadt,Germany).Two
independent observers in a blinded manner scored both
HIF-1𝗼 and VEGF-A renal staining as negative, mild, mod-
erate, and intense. The final score was the mean of the two
evaluations.
2.2. Cell Culture. Human kidney HK-2 cells were purchased
from American Type Culture Collection (Rockville, MD,
USA). YC-1 was purchased from Sigma Chemical Co. (St.
Louis, MO, USA), monoclonal HIF-1𝗼 (1:1000) (Transduc-
tionLaboratories,BDBiosciences,PaloAlto,CA,USA);poly-
clonal𝗽-actin(1:10000)wasobtainedfromSigma.Cellswere
maintained in DMEM supplemented with 10% foetal bovine
serum (FBS), 1% penicillin/streptomycin/amphotericin B
(Invitrogen,Carlsbad,CA,USA)and1%Insulin-Transferrin-
Selenium (Sigma, St. Louis, MO, USA). Cells were routinely
cultured in 95% air, 5% CO2 (normoxic conditions) at 37
∘C.
In all experiments, cells were plated at 70–90% confluence,
and when completely attached, they were treated with LPS
i ns e r u mc o m p l e t em e d i a .W h e nn e c e s s a r y ,c e l l sw e r ea l s o
treated with AGE, albumin, or YC-1 under the conditions
specified in the legends to figures.
2.3. Single-Step Real-Time Quantitative RT-PCR. Total cell
RNA from HK-2 cells was isolated with TriReagent (Sigma,
St.Louis,MO,USA),andreal-timequantitativeRT-PCRana-
l y s i sw a sp e r f o r m e di n2 n gs a m p l e su s i n gS Y B RG r e e n
PCR master mix (Applied Biosystems), in one-step RT-PCR
protocol as previously described [20]. Primer sequences for
genes were as follows (sequences 5
򸀠-3
򸀠): VEGF165 sense:
GACAAGAAAATCCCTGTGGGCAAC, antisense: GCG-
AGTCTGTGTTTTTGC; 𝗽-actin sense: AGAAGGATTCC-
TATGTGGGCG and antisense: CATGTC CCAGTTGGT-
GAC.Journal of Diabetes Research 3
2.4. Protein Isolation and Western Blotting. HK-2 cells were
incubated with albumin or AGE (100𝜇g/mL each) or in
combination with LPS (1𝜇g/mL) for different periods. Cells
werewashedtwicewithice-coldPBS,thenharvested,scraped
into ice-cold PBS, and then pelleted by centrifugation at 500
×gf o r5m i na t4
∘C. In order to obtain cell lysates, the cells
were kept on ice for 30min in a solution containing 50mM
Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 0.5%
sodiumdeoxycholate,andproteaseinhibitors.Thereafter,the
c e l l sw e r ep e l l e t e db yc e n t r i f u g a t i o na t4 0 0 0×gf o r5m i na t
4
∘C. Proteins from cell lysates were denatured by heating.
Then, they were resolved by 10% SDS-PAGE and blotted on a
nitrocellulosemembrane(BioTrace/NT)overnightin50mM
Tris-HCl, 380mM glycin, 0.1% SDS, and 20% methanol.
Mouse anti-HIF-1𝗼 (1:1000) antibody (BD Biosciences, CA,
USA) was added followed by incubation overnight at 4
∘C.
After treatment for 1h at room temperature with the cor-
responding secondary antiserum (1:4000), the signals were
detected with enhanced chemiluminescence reagent (GE
Healthcare-Life Science, NJ, USA) using 𝗽-actin antibody
(Calbiochem-Merk Bioscience, USA) as loading control.
For HIF-1𝗼 i n h i b i t i o n ,w eu s e dH I F - 1 𝗼 siRNA sc-44225
(Santa Cruz Biotechnologies, CA, USA) for HIF-1𝗼 con-
taining 3 sequences against 3 different HIF-1𝗼 exons and
scramble siRNA AM4637 (Ambion) as a control as previ-
ously described [16]. HK-2 cells at 70% of confluence were
transfected with 100nM HIF-1𝗼 siRNA or 100nM scramble
siRNA. According to the manufacturer’s protocol, we used
Lipofectamine 2000 to get the transfection. HIF-1𝗼 interfer-
ence was evaluated by qRT-PCR for HIF-1𝗼 mRNA.
2.5.StatisticalAnalysis. Resultsareexpressedasmean±SEM
throughout the text. Animal data was analyzed by either
the Kruskal-Wallis test or Mann-Whitney test, when appro-
priate. Unless otherwise specified, in vitro experiments were
repeated at least three times, and the statistical analysis was
performed by the Bonferroni test. In all cases, a 𝑃 < 0.05 was
considered statistically significant.
3. Results
3.1. Characterization of LPS-Induced AKI in Diabetic Mice
Model. As shown in Figure 1,d i a b e t i ca n i m a l sa ft e r6w e e k s
o fS T Zd i s p l a yas i g n i fi c a n ti n c r e a s ei nt h eU A Et h r o u g h o u t
the study. Both groups of animals also showed a significant
increase of this parameter at 18–24h after LPS injection.
Although six hour after LPS, diabetic and nondiabetic mice
developedasimilardegreeofdecreaseofrenalfunction,only
diabetic animals showed a recovery of this parameter at 24h
to a level not significantly different from those of the control
animals(Figure 2).Onthecontrary,nondiabeticmicedidnot
show a complete recovery of the renal function throughout
the period of the study (72h) (Figure 2). As expected,
these changes were associated with an increased Urine
Volume (UV) in diabetic mice, and a decrease in the UV in
nondiabetic mice (Figure 3). Moreover, while diabetic mice
did not show any significant changes in the NaFE throughout
the study, nondiabetic mice displayed a significant decrease
in this parameter (Figure 4). This maintained renal sodium
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Figure 1: Urinary Albumin Excretion (UAE) in diabetic and
nondiabetic LPS-injected mice. Values are mean ± SEM.
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Figure2:Renalfunction(endogenouscreatinineclearance(CCr)in
diabetic(blackbars)andnondiabetic(openbars)LPS-injectedmice.
Values are mean ± SEM.
∗𝑃 < 0.05 versus control value,
∗∗𝑃 < 0.01
versus control value, and a 𝑃 < 0.01 versus nondiabetic.
reabsorption capacity observed in the diabetic mice is in
accordance with a functional or mild form of AKI [21].
3.2. Renal Expression and Immunolocalization of HIF-1𝗼 and
VEGF-A. Western-blottinganalysisrevelsthatLPSincreased
the expression of HIF-1𝗼 in both groups of animals, albeit
it was even higher in the diabetic group (Figure 5(a)). Inter-
estingly, the condition of diabetes itself was able to induce a
significant upregulation of this protein.
In the kidney of control animals, an intense immuno-
expression to HIF-1𝗼 was observed in the cytoplasm and
several nuclei of the proximal convoluted tubules, and a
weak signal was observed in the nuclei of distal tubules
(Figure 5(b), I). By contrast,5 weeks after diabetes induction,
the mouse kidney displayed a higher number of positive
tubuloepithelialnuclei,showingan increaseinthecytoplasm
immunoreactivity (Figure 5(b), II).4 Journal of Diabetes Research
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Figure 3: Urinary volume in diabetic (black bars) and nondiabetic
(open bars) LPS-injected mice. Values are mean ± SEM.
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Figure 4: Fractional excretion of sodium (NaFE) in diabetic (black
bars) and nondiabetic (open bars) LPS-injected mice. Values are
mean ± SEM.
∗𝑃 < 0.05 versus control value and a 𝑃 < 0.01 versus
nondiabetic.
In LPS-treated mice, both the nucleus and cytoplasm of
renal tubules showed a strong immunoexpression to HIF-1𝗼
antibody (Figure 5(b), III) and this labelling was even greater
in diabetic LPS-treated mice (Figure 5(b),I V ) .
To analyze if the observed HIF-1𝗼 upregulation was
tra n scri p tio nall yacti v einvi v o ,w ea nal yzedtheexp r essio no f
the HIF-1𝗼 target gene VEGF-A, by immunostaining in mice
kidneys. We first observed that while control mice did not
show VEGF-A staining, diabetic mice display some degree
of expression of this protein. Although all LPS-treated mice
display a significant increase in the expression of VEGF-A
in comparison with their respective controls, diabetic LPS-
treated mice showed the highest immunolabeling (Figure 6).
3.3. Glycated AlbuminSynergizes with LPS to Upregulate HIF-
1𝗼 in HK-2 Renal Cells. We then performed an in vitro
approach in order to get inside into the cellular mechanism
responsible for the observed upregulation of both HIF-1𝗼
and VEGF-A in the kidney of diabetic mice. It has been
previously described that AGE increases VEGF expression
in retinal epithelial cells through activation of HIF-1𝗼 [22].
AGEisthemajorformofcirculatingglycatedproteinsinvivo,
and its levels are increased in diabetes [23, 24]. Furthermore,
AGE elicits pathobiological effects in cultured renal cells
that are identical to those of high glucose ambient [23].
Therefore, in order to assess the effect of the diabetic milieu
on the expression of HIF-1𝗼 in proximal tubular cells, HK-
2c e l l sw e r ei n c u b a t e dw i t h1 0 0𝜇g/mL AGE or albumin for
up to 6h. In these conditions, HIF-1𝗼 was upregulated in
a time-dependent manner in AGE-treated cells, but not in
cells treated with albumin, and its expression reached its
maximum after 4h incubation (Figure 7(a)).
We then assessed whether LPS affects AGE-induced
HIF-1𝗼 upregulation, since a hypothetical synergy for HIF-
1𝗼 expression in the proximal tubule could contribute to
better recovery of renal function in diabetic mice after
experimental endotoxemia. HK-2 cells were preincubated
with either 100𝜇g/mL AGE or 100𝜇g/mL albumin for 1h
and then with 1𝜇g/mL LPS for 5h. Expression of HIF-1𝗼 was
increased to a similar degree by AGE and LPS, but it was
dramatically enhanced in cells which were incubated with
bothagents(Figure 7(b)).TheseresultssuggestthatAGEand
LPS increased HIF-1𝗼 expression in the proximal tubules, in
a synergistic manner.
3.4. Glycated Albumin-Induced HIF-1𝗼 Promotes the Upregu-
lation of the Renoprotective VEGF-A in HK-2 Renal Cells. To
demonstrate that AGE-induced HIF-1𝗼 was transcriptionally
active, we determined by Q-RT-PCR the mRNA levels of
VEGF-A in HK-2 cells treated with either 100𝜇g/mL GA or
100𝜇g/mL albumin for 5h. VEGF mRNA expression (Figure
8) was substantially increased by AGE but not by albumin.
In order to establish the dependency on HIF-1𝗼 of AGE-
induced increase in VEGF-A mRNA expression, cells were
preincubated with HIF-1𝗼 inhibitor YC-1 or transfected with
specific HIF-1𝗼 siRNA. Both treatments abolished AGE-
induced increase in VEGF-A mRNA expression (Figure 8),
which confirmed that the AGE effect on VEGF-A expression
is dependent on HIF-1𝗼.
4. Discussion
Althoughitisknownthatrodentswithexperimentaldiabetes
are protected from certain nephrotoxic agents [1–3], most
of the available data are based upon experimental models
of an early diabetic stage, condition characterized by the
presence of renal cell proliferation, and thus renal cells are
not quiescent as occurred in adult subjects [25, 26]. Thus, as
reported by Zhang et al. [25], an inherently proproliferative
state of the diabetic kidney may explain the observed lower
expansion of renal injury on the one hand and recovery due
to higher proliferative response after injury on the other. The
same also accounts for HIF-1𝗼 where available data is limited
to an early diabetic stage. Thus, herein we studied the role of
HIF-1𝗼 i nt h eo u t c o m eo fA K Ii nd i a b e t i ca n i m a l sa ft e rt h e
development of proteinuria.
AKI is a syndrome defined by an abrupt change in the
renal function and/or urine output which could range from
overttubularnecrosistomildperturbationsinrenalfunction
w i t h o u ts i g n i fi c a n tp a t h o l o g i cc h a n g e s( p r e r e n a la z o t e m i a )
[18]. In our study, we observed that diabetic mice, besides
an increase in the UAE, display better recovery of renalJournal of Diabetes Research 5
Actin
1.04 2.40 1.70 3.81
Control LPS 24 h DB DB + LPS 24 h
HIF-1𝗼
(a)
II I
III IV
∗
(b)
Figure5:(a)Western-blottinganalysisofHIF-1𝗼inrenaltissue.QuantificationofHIF-1𝗼signalnormalizedby𝗽-actinsignalisalsoshown.
(b) HIF-1𝗼 immunohistochemistry. I: control kidney. An intense immunoexpression of HIF-1𝗼 was detected in the cytoplasm of proximal
convoluted tubules (∗), and in the nuclei of distal tubules, the labelling was weaker (→). II: diabetic mice. Proximal tubules showed positive
reaction to HIF-1𝗼 in the cytoplasm (◼). Both nucleus and cytoplasm of distal convoluted tubules cells (򳵳) presented a positive reaction to
HIF-1𝗼. The arrow points to the urinary pole with moderate reaction to this antibody. III: LPS-treated mice. Both convoluted tubules showed
astrongimmunolabellingtoHIF-1𝗼.IV:diabeticLPS-treatedmice.ThehighestreactiontoHIF-1𝗼wasencounteredinthekidneyofdiabetic
mice treated with endotoxin. Magnification: I and II: ×600; III and IV: ×300.
function after experimental endotoxemia. The maintained
renal sodium reabsorption capacity observed in the diabetic
mice is in accordance with a functional or mild form of AKI
[21]. Furthermore, no alterations of the renal structure in any
of the animal groups studied were found.
Thisisinterestingduetothefactthatproteinuriaisawell-
known factor involved in the progression of renal damage
by mechanisms which include alterations in tubuloepithelial
cell growth, apoptosis, gene transcription, and inflammatory
cytokine production [27]. Furthermore, multiple clinical
trials have indicated that antiproteinuric strategies are, in
general, renoprotective [27]. Herein we demonstrate that in
the diabetic kidney, endotoxemia could trigger the upregula-
tion of HIF1-1𝗼 even in the proteinuric stage of the disease.
It is known that renal proximal tubular epithelial cells
are targets for LPS during sepsis and renal infections. Septic
AKIischaracterizedbyapaucityoftubularcelldeathdespite
often severe impairment of global function. Accumulating
data suggest that the renal tubules are also heavily involved
in the pathogenesis of diabetic nephropathy [16]. In diabetes,
t u b u l a ri n j u r yi nt h ek i d n e yi sd u et os e v e r a lf a c t o r s ,p a r -
ticularly high glucose levels, albuminuria, and the presence
of advanced glycation end-product modified proteins. We
show here that either LPS or AGE increases the expression of
HIF-1𝗼 in HK-2 cells to a similar extent, and that exposure
of AGE-treated cells to LPS results in overexpression of
HIF-1𝗼. Interestingly, renal expression of HIF-1𝗼 was also
increasedinseveralareas,includingproximaltubules,inboth
diabetic and LPS-treated mice, and maximal renal HIF-1𝗼
upregulation was found in diabetic mice treated with LPS.
Accumulating evidence indicates that there is a fine line
betweenthepotentialbenefitandharmfulsideeffectsofHIF-
1𝗼activation.Forinstance,amongthenoxiouseffectsofHIF-
1𝗼, which is related to our experimental setting, it is worth6 Journal of Diabetes Research
II I
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Figure6:VEGF-Aimmunohistochemistry.I:controlkidney.VEGF-Awasnotdetectedinthekidneyofcontrolmice.II:diabeticmice.Some
of proximal tubules cells showed positive reaction to VEGF-A in the cytoplasm (right arrow). Endothelial cellswerealsoimmunostained(left
arrow). III: LPS-treated mice. In some cells of convoluted tubules, VEGF-A was located in the cytoplasm with a granular pattern; in the other
tubules, VEGF-A antibody showed a diffuse labelling. IV: diabetic LPS-treated mice. The highest reaction to VEGF-A was encountered in the
kidney of diabetic mice treated with endotoxin. Magnification ×300.
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Figure7:AGEandLPSinduceHIF-1𝗼upregulationandcooperatetoover-increaseHIF-1𝗼expression.(a)AGEinducesHIF-1𝗼upregulation.
(b) LPS induces HIF-1𝗼 upregulation and synergizes with AGE to over-increase HIF-1𝗼 expression. Equal protein loading was confirmed by
probing with an anti-𝗽-actin antibody. Normalized density ratio of HIF-1𝗼 over 𝗽-actin is indicated for each band.
mentioning that hypoxia-dependent increased tubular activ-
ityofHIF-1𝗼hasbeenproposedasacontributingfactorinthe
development of tubulointerstitial fibrosis in diabetes mellitus
[16]. In addition, HIF-1𝗼 has been shown to play an essential
role in the development of LPS-induced sepsis in mice, so
that targeted deletion of HIF-1𝗼 has a protective effect [28].
On the other hand, HIF-1𝗼 inducer cobalt chloride improves
disease manifestations in a variety of kidney disease models
includingdiabeticnephropathyandhypoxicpreconditioning
ameliorates LPS-induced renal dysfunction [29]. Moreover,
it has been recently published that HIF-1𝗼 promotes renal
ischemic injury regeneration [30]. According to the latter
observation, it is tempting to speculate that the increased
renal expression of HIF-1𝗼 in diabetic mice, particularly in
the proximal tubules, might contribute to better recovery of
renal function after experimental endotoxemia.
Regarding potential mechanisms triggered by HIF-1𝗼 for
contributing to renal recovery in our model, it is conceiv-
able that VEGF induction as HIF-1𝗼 target gene might be
mediating. VEGF has been described as a survival factor for
proximal tubule cells [23] and critical for maintenance of
renal vasculature during kidney damage including AKI [31].
Our present data indicating that VEGF is induced in LPS-
treated diabetic mice further support this notion.
In conclusion, we have found that mice with diabetic
nephropathy display better recovery of renal function after
experimental endotoxemia than their control littermates.
This finding was associated with an increased expression ofJournal of Diabetes Research 7
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Figure 8: AGE increases VEGF mRNA expression in a HIF-1𝗼-
dependent manner. Cells were preincubated with HIF-1𝗼 inhibitor
YC-1ortransfectedwithHIF-1𝗼siRNAorcontrolsiRNA(scramble)
asindicatedinSection 2.Thentheywereincubatedwithalbuminor
AGE, and VEGF mRNA expression was quantified by Q-RT-PCR.
Bars are the mean ± SD of 3 different experiments.
∗𝑃 < 0.01 versus
albumin;
+𝑃 < 0.01 versus AGE.
both HIF-1𝗼 and VEGF-A in the tubule epithelium of the
diabetic mice. Furthermore, in these cells, AGE was found
to be capable of upregulating HIF-1𝗼 as well as VEGF-A, a
s u r v i v a lf a c t o rf o rt h e s ec e l l s .O u rfi n d i n g ss u g g e s tt h a te v e n
in the presence of an increased UAE, the diabetic condition
may display upregulation of HIF-1𝗼 that might function as a
“precondition state” capable of protecting from renal damage
such as endotoxic AKI.
Conflict of Interests
The authors declared that they have no conflict of interests.
Acknowledgments
N .O l e ai sr e c i p i e n to faR e s e a r c hC o n t r a c tf r o mC o m u n i d a d
Aut´ onoma de Madrid, Programa de Actividades I+D en
Biociencias 2010 (S2010/BMD-2378). A. Fern´ andez is the
recipient of a postdoctoral fellowship from the Junta de
Comunidades de Castilla-La Mancha. This work was sup-
ported in part by Grants from Ministerio de Ciencia e Inno-
vaci´ on (SAF2009-12009-C02-01), SAF2011-26838, Junta de
Comunidades de Castilla-La Mancha (POII10-0034-0322),
Instituto Salud Carlos III (PI12/02825), FIS PS 09/02183, and
the Eugenio Rodr´ ıguez Pascual Foundation.
References
[1] W. C. Elliott, D. C. Houghton, and D. N. Gilbert, “Exper-
imental gentamicin nephrotoxicity: effect of streptozotocin-
induced diabetes,” Journal of Pharmacology and Experimental
Therapeutics,v o l .2 3 3 ,n o .1 ,p p .2 6 4 – 2 7 0 ,1 9 8 5 .
[2] K. Hamilton, E. J. Eaton, H. O. Garland, and S. Old, “Effect
of experimental diabetes mellitus on gentamicin-induced acute
renal functional changes in the anaesthetized rat,” Clinical and
Experimental Pharmacology and Physiology,v o l .25 ,n o .3 -4 ,p p .
231–235, 1998.
[ 3 ]A .V .D n y a n m o t e ,S .P .S a w a n t ,E .A .L o c k ,J .R .L a t e n d r e s s e ,
A. A. Warbritton, and H. M. Mehendale, “Diabetic mice
are protected from normally lethal nephrotoxicity of S-1,2-
dichlorovinyl-L-cysteine (DCVC): role of nephrogenic tissue
repair,” Toxicology and Applied Pharmacology,v o l .211,no .2,p p .
133–147, 2006.
[4] M. R. Rudnick, S. Goldfarb, L. Wexler et al., “Nephrotoxicity
of ionic and nonionic contrast media in 1196 patients: a rando-
mized trial,” Kidney International,v o l .4 7 ,n o .1 ,p p .2 5 4 – 2 6 1 ,
1995.
[ 5 ]P .A .M c C u l l o u g h ,R .W o l y n ,L .L .R o c h e r ,R .N .L e v i n ,a n d
W. W. O’Neill, “Acute renal failure after coronary intervention:
incidence, risk factors, and relationship to mortality,” American
Journal of Medicine,v o l .1 0 3 ,n o .5 ,p p .3 6 8 – 3 7 5 ,1 9 9 7 .
[ 6 ]C .V .Th a k a r ,S .A r r i g a i n ,S .W o r l e y ,J . - P .Y a r e d ,a n dE .P .
Paganini, “A clinical score to predict acute renal failure after
cardiac surgery,” Journal of the American Society of Nephrology,
v o l .1 6 ,n o .1 ,p p .1 6 2 – 1 6 8 ,2 0 0 5 .
[7] M.H.RosnerandM.D.Okusa,“Acutekidneyinjuryassociated
withcardiacsurgery,”Clinical Journal of theAmericanSociety of
Nephrology,v o l .1 ,n o .1 ,p p .1 9 – 3 2 ,2 0 0 6 .
[8] M.D. Griffin,E.J.Bergstralh,andT.S. Larson,“Renalpapillary
necrosis a sixteen-year clinical experience,” Journal of the
American Society of Nephrology,v o l .6 ,n o .2 ,p p .2 48 – 25 6 ,1 9 9 5 .
[9] G.L.Semenza,“Signaltransductiontohypoxia-induciblefactor
1,” Biochemical Pharmacology,v o l .6 4 ,n o .5 - 6 ,p p .9 9 3 – 9 9 8 ,
2002.
[10] J. Kanellis, S. Fraser, M. Katerelos, and D. A. Power, “Vascular
endothelial growth factor is a survival factor for renal tubular
epithelial cells,” A m e r i c a nJ o u r n a lo fP h y s i o l o g y ,v o l .2 7 8 ,n o .6 ,
p p .F 9 0 5 – F 9 1 5 ,2 0 0 0 .
[11] P.Jaakkola,D.R.Mole,Y.-M.Tianetal.,“TargetingofHIF-𝗼to
thevonHippel-LindauubiquitylationcomplexbyO2-regulated
prolyl hydroxylation,” Science,v o l .2 9 2 ,n o .5 5 1 6 ,p p .4 6 8 – 4 7 2 ,
2001.
[ 1 2 ]M .I v a n ,K .K o n d o ,H .Y a n ge ta l . ,“ H I F 𝗼 targeted for VHL-
mediateddestructionbyprolinehydroxylation:implicationsfor
O2 sensing,” Science,v o l .2 9 2 ,n o .5 5 1 6 ,p p .4 6 4 – 4 6 8 ,2 0 0 1 .
[13] S. Kaluz, M. Kaluzov´ a, and E. J. Stanbridge, “Regulation of
gene expression by hypoxia: integration of the HIF-transduced
hypoxic signal at the hypoxia-responsive element,” Clinica
Chimica Acta,v o l .3 9 5 ,n o .1 - 2 ,p p .6 – 1 3 ,2 0 0 8 .
[14] J. Zhou and B. Brune, “Cytokines and hormones in the regula-
tion of hypoxia inducible factor-1alpha (HIF-1alpha),” Cardio-
vascular & Hematological Agents in Medicinal Chemistry,v o l .4 ,
n o .3 ,p p .1 8 9 – 1 9 7 ,2 0 0 6 .
[15] I.R.Botusan,V .G.Sunkari,O .Sa vuetal.,“ Stabiliza tionofHIF -
1𝗼 is critical to improve wound healing in diabetic mice,” Pro-
ceedings of the National Academy of Sciences of the United States
of America,v o l .1 0 5 ,n o .4 9 ,p p .1 9 4 2 6 – 1 9 4 3 1 ,2 0 0 8 .
[16] M. Nangaku, R. Inagi, T. Miyata, and T. Fujita, “Hypoxia and
hypoxia-induciblefactorinrenaldisease,”Nephron,v o l .11 0,no .
1, article e1, 2008.
[17] C. C. Tisher and T. H. Hostetter, “Diabetic nephropathy,” in
Renal Pathology, C. C. Tisher and B. M. Brenner, Eds., vol. 2,
JB Lippincott, Philadelphia, Pa, USA, 1994.
[18] C. E. Guthrow, M. A. Morris, and J. F. Day, “Enhanced nonen-
zymatic glucosylation of human serum albumin in diabetes8 Journal of Diabetes Research
mellitus,” Proceedings of the National Academy of Sciences of the
United States of America,v o l .7 6 ,n o .9 ,p p .4 2 5 8 – 4 2 6 1 ,1 9 7 9 .
[19] A. Izquierdo, P. L´ opez-Luna, A. Ortega et al., “The parathyroid
hormone-relatedproteinsystemanddiabeticnephropathyout-
comeinstreptozotocin-induceddiabetes,”KidneyInternational,
v o l .6 9 ,n o .1 2 ,p p .2 1 7 1 – 2 1 7 8 ,2 0 0 6 .
[20] A. B. Fernandez-Martinez, M. I. Jimenez, I. S. Hernandez et al.,
“Mutual regulation of hypoxic and retinoic acid related signall-
ing in tubular proximal cells,” International Journal of Biochem-
istry & Cell Biology,v o l .4 3 ,n o .8 ,p p .1 1 9 8 – 1 2 0 7 ,2 0 1 1 .
[21] A.A.SharfuddinandB.A.Molitoris,“Pathophysiologyofisch-
emicacutekidneyinjury,”Nature Reviews Nephrology,vol.7 ,no .
4, pp. 189–200, 2011.
[22] C. Treins, S. Giorgetti-Peraldi, J. Murdaca, and E. Van Ob-
berghen, “Regulation of vascular endothelial growth factor
expression by advanced glycation end products,” Journal of
Biological Chemistry,v o l .2 7 6 ,n o .4 7 ,p p .4 3 8 3 6 – 4 3 8 4 1 ,2 0 0 1 .
[23] C. E. Guthrow, M. A. Morris, and J. F. Day, “Enhanced nonen-
zymatic glucosylation of human serum albumin in diabetes
mellitus,” Proceedings of the National Academy of Sciences of the
United States of America,v o l .7 6 ,n o .9 ,p p .4 2 5 8 – 4 2 6 1 ,1 9 7 9 .
[24] M. P. Cohen and F. N. Ziyadeh, “Role of Amadori-modified
nonenzymatically glycated serum proteins in the pathogenesis
of diabetic nephropathy,” Journal of the American Society of
Nephrology,v o l .7 ,n o .2 ,p p .1 8 3 – 1 9 0 ,1 9 9 6 .
[25] Y. Zhang, Y. Shi, Y. Liu et al., “Growth pattern switch of renal
cells and expression of cell cycle related proteins at the early
s t a g eo fd i a b e t i cn e p h r o p a t h y , ”Biochemical and Biophysical
Research Communications,v o l .3 6 3 ,n o .1 ,p p .1 5 9 – 1 6 4 ,2 0 0 7 .
[26] S. V. Griffin and S. J. Shankland, “Renal hyperplasia and hyper-
trophy: role of cell cylce regulatory proteins,” in The Kidney
Physiology and Pathophysiology,R .J .A l p e r na n dS .C .H e b e r t ,
Eds., chapter 27, pp. 723–742, New York, NY, USA, 2008.
[27] R.J.BainesandN.J.Brunskill,“Tubulartoxicityofproteinuria,”
Nature Reviews Nephrology,v o l .7 ,n o .3 ,p p .1 7 7 – 1 8 0 ,2 0 1 1 .
[28] M. Thiel, C. C. Caldwell, S. Kreth et al., “Targeted deletion
of HIF-1𝗼 gene in T cells prevents their inhibition in hypoxic
inflamedtissuesandimprovessepticmicesurvival,”PLoS ONE,
vol. 2, no. 9, article e853, 2007.
[29] S.Ohtomo,M.Nangaku,Y .Izuhara,S.T akizawa,C.V .Y .D .Stri-
hou,andT .Miyata,“Cobaltamelioratesrenalinjuryinanobese,
hypertensive type 2 diabetes rat model,” Nephrology Dialy-
sis Transplantation,v o l .2 3 ,n o .4 ,p p .1 1 6 6 – 1 1 7 2 ,2 0 0 8 .
[30] E.Conde,L.Alegre,I.Blanco-S´ anchezetal.,“Hypoxiainducible
factor 1-alpha (hif-1 alpha) is induced during reperfusion after
renal ischemia and is critical for pr o x i m a lt u b u l ec e l ls u r v i v a l , ”
PLoS ONE,v o l .7 ,n o .3 ,A r t i c l eI De 3 3 2 5 8 ,2 0 1 2 .
[31] E. C. Leonard, J. L. Friedrich, and D. P. Basile, “VEGF-121 pre-
serves renal microvessel structure and ameliorates secondary
renal disease following acute kidney injury,” American Journal
of Physiology,v o l .2 9 5 ,n o .6 ,p p .F 1 6 4 8 – F 1 6 5 7 ,2 0 0 8 .Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com